Dear Valued Client,
In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in mind that we announce an update to our 13710: Novel Emerging Compounds Panel effective with orders placed on or after January 30th, 2023.
The changes to the 13710: Novel Emerging Compounds Panel will include the addition of the following compounds:
- · Dimethylpentylone
- · Alpha-PHP
- · Alpha-PiHP
- · Flubromazepam
- · Bromazolam
- · Tianeptine
- · Phenibut
Additionally, these analytes will also be included in our 70510: Comprehensive Panel, Blood with Analyte Assurance™.
You can always find the most recent publication for our panel offerings on our Test Catalog, found at www.axisfortox.com.
For specific questions regarding our tests or tests not found on our Test Catalog, please contact our Lab Client Support Team at [email protected].
We look forward to serving you.
Director of Operations & Product Management